Want to see ADMT full AI Analyst Report?
ADMT Stock Chart & Stats
$0.04
<$0.01(2.75%)
At close: 4:00 PM EDT
$0.04
<$0.01(2.75%)
Day’s Range― - ―
52-Week Range$0.02 - $0.12
Previous CloseN/A
Volume1.50K
Average Volume (3M)13.49K
Market Cap
$2.64M
Enterprise Value$6.57
Total Cash (Recent Filing)$255.73K
Total Debt (Recent Filing)$741.26K
Price to Earnings (P/E)―
Beta0.06
Next Earnings
Aug 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding67,588,490
10 Day Avg. Volume10,740
30 Day Avg. Volume13,493
Financial Highlights & Ratios
PEG Ratio3.60
Price to Book (P/B)10.65
Price to Sales (P/S)1.82
P/FCF Ratio-49.03
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Business ModelADM Tronics runs two distinct revenue streams—electronics contract manufacturing and proprietary medical products—which provides structural diversification of demand and cash flow. This reduces single-market dependency, supports cross-selling of services, and cushions the business against sector-specific downturns over the next several months.
Historical Gross Margin StrengthReported healthy gross margins in 2023–2025 indicate the company can achieve attractive unit economics when operations and volumes are stable. That suggests durable manufacturing efficiencies and product mix advantages that can support profitability recovery if revenue steadies, contributing to longer-term margin sustainability.
Recent Reduction In Total DebtA reduction in total debt versus the prior year signals early deleveraging and improved financial flexibility. If sustained, this trend lowers interest expense pressure and refinancing risk, improving the company’s ability to fund working capital, invest in product commercialization, and withstand near-term operating volatility.
Bears Say
Inconsistent Revenue And Repeated LossesThe history of uneven revenue and recurring net losses undermines predictability of cash flows and weakens bargaining power with suppliers and customers. Persistent unprofitability limits retained earnings, reduces reinvestment capacity, and raises the execution burden on management to deliver sustainable profitable growth over the medium term.
Volatile, Often-negative Cash GenerationRepeated negative operating and free cash flow implies the company frequently cannot self-fund operations or growth, increasing reliance on external financing. That constrains ability to invest in production capacity or commercialize medical products, and raises liquidity risk if capital markets tighten or margins compress further.
Rising Leverage And Declining EquityElevating leverage and materially lower equity reduce the company’s financial cushion and increase vulnerability to shocks. Higher debt ratios raise interest and covenant risk, limit strategic flexibility, and can force defensive capital allocation choices that impede long-term investment in R&D or commercialization of its medical technologies.
ADM Tronics Un News
ADMT FAQ
What was ADM Tronics Unlimited Inc’s price range in the past 12 months?
ADM Tronics Unlimited Inc lowest stock price was $0.02 and its highest was $0.12 in the past 12 months.
What is ADM Tronics Unlimited Inc’s market cap?
ADM Tronics Unlimited Inc’s market cap is $2.64M.
When is ADM Tronics Unlimited Inc’s upcoming earnings report date?
ADM Tronics Unlimited Inc’s upcoming earnings report date is Aug 24, 2026 which is in 9 days.
How were ADM Tronics Unlimited Inc’s earnings last quarter?
ADM Tronics Unlimited Inc released its earnings results on Jul 10, 2026. The company reported -$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is ADM Tronics Unlimited Inc overvalued?
According to Wall Street analysts ADM Tronics Unlimited Inc’s price is currently Overvalued.
Does ADM Tronics Unlimited Inc pay dividends?
ADM Tronics Unlimited Inc does not currently pay dividends.
What is ADM Tronics Unlimited Inc’s EPS estimate?
ADM Tronics Unlimited Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ADM Tronics Unlimited Inc have?
ADM Tronics Unlimited Inc has 67,588,490 shares outstanding.
What happened to ADM Tronics Unlimited Inc’s price movement after its last earnings report?
ADM Tronics Unlimited Inc reported an EPS of -$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -23.077%.
Which hedge fund is a major shareholder of ADM Tronics Unlimited Inc?
Currently, no hedge funds are holding shares in ADMT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ADM Tronics Unlimited Inc
ADM Tronics Unlimited, Inc. (ADMT), established in 1969 and headquartered in Northvale, New Jersey, is a company that develops, manufactures, and markets electronic solutions. Its products are primarily designed for non-invasive medical applications, though they also serve other industries, with sales reaching the United States, Australia, Asia, and Europe. The company structures its business across three main divisions: Electronics, Chemical, and Engineering. Within its Electronics segment, ADMT creates specialized devices essential for diagnosing and treating both humans and animals, alongside providing electronic control systems for spas and hot tubs. The Chemical division offers a broad spectrum of water-based products, including primers, adhesives, coatings, resins, and chemical additives. This segment also manufactures anti-static conductive paints, coatings, and related items. Furthermore, it produces water-based, adhesive topical formulations for maxillofacial prosthetic medical applications, as well as for professional makeup artistry, especially in film, television, and theatrical settings. Finally, the Engineering segment delivers extensive services encompassing research, development, and regulatory support. These services are vital for the design, development, and manufacturing of medical devices, various electronic systems, and other advanced technologies and products, including those related to medical electronic therapeutic technology.
Technical Analysis
Ownership Overview
―
Insiders
―
Mutual Funds
0.12% Other Institutional Investors
99.88% Public Companies and
Individual Investors



